Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Practice Point
  • Published:

Should infliximab be used to help maintain glucocorticosteroid-induced remission in patients with giant cell arteritis?

Nature Clinical Practice Rheumatology volume 3, pages 600–601 (2007)Cite this article

boxed-textHoffman GS et al. (2007) Infliximab for maintenance of glucocorticosteroid-induced remission of giant cell arteritis: a randomized trial. Ann Intern Med 146: 621–630

Another disappointment in the search for alternative therapies for GCA emphasizes the importance of maximizing steroid withdrawal in order to minimize the adverse effects of glucocorticoids

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Salvarini C et al. (2007) Infliximab plus prednisone for the initial treatment of polymyalgia rheumatica: a randomized trial. Ann Intern Med 146: 631–639

    Article  Google Scholar 

  2. Booth A et al. (2004) Prospective study of TNFα blockade with infliximab in anti-neutrophil cytoplasmic antibody-associated systemic vasculitis. J Am Soc Nephrol 15: 717–721

    Article  CAS  Google Scholar 

  3. Wegener's Granulomatosis Etanercept Trial (WGET) Research Group (2005) Etanercept plus standard therapy for Wegener's granulomatosis. N Engl J Med 352: 351–361

  4. Weyand CM et al. (1997) Disease patterns and tissue cytokine profiles in giant cell arteritis. Arthritis Rheum 40: 19–26

    Article  CAS  Google Scholar 

  5. Schneeweiss S et al. (2007) Anti-tumor necrosis factor α therapy and the risk of serious infection in elderly patients with rheumatoid arthritis. Arthritis Rheum 56: 1754–1764

    Article  CAS  Google Scholar 

Download references

Acknowledgements

The synopsis was written by Helen Jaques, Editorial Assistant, Nature Clinical Practice.

Author information

Author notes

  1. Department of Rheumatology, Division of Immunity and Infection, Medical School, University of Birmingham, Edgbaston, Birmingham B15 2TT, UK p.a.bacon@bham.ac.uk

Authors and Affiliations

  1. PA Bacon is Professor Emeritus in the Department of Rheumatology, Division of Immunity and Infection at the University of Birmingham, UK.,

    Paul A Bacon

Authors
  1. Paul A Bacon
    View author publications

    You can also search for this author in PubMed Google Scholar

Ethics declarations

Competing interests

The author declares no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Bacon, P. Should infliximab be used to help maintain glucocorticosteroid-induced remission in patients with giant cell arteritis?. Nat Rev Rheumatol 3, 600–601 (2007). https://doi.org/10.1038/ncprheum0623

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ncprheum0623

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing